Teva Pharmaceuticals Poland will have a new CEO - Ewa Królikowska, previously commercial director of RX and vice president of distribution, will take over the position in April 2024. She will lead the commercial team of the company, which is a global leader in the pharmaceutical market and one of...
The drug program in operation in Poland for patients with retinal diseases (B.70) is world-class, experts agree. Since January, it has been reimbursing pharizymab, a bispecific antibody with high efficacy, administered by injections into the eye up to once every four months. Ophthalmologists...
The Purple Day holiday has been celebrated since 2008 and still hardly anyone in Poland has heard of it. - Today I, Alicia from EPI-BOHATER, have this little dream that you join in raising awareness and spreading knowledge about epilepsy. Epilepsy affects our lives, but it doesn't define who we...
As of April 1, 2024, patients with multiple sclerosis will have access to a new subcutaneous form of natalizumab therapy administration. According to Prof. Monika Adamczyk-Sowa, MD, head of the Department of Neurology in Zabrze at the Silesian Medical University in Katowice, and president of the...
Immunotherapy is entering very strongly into the treatment of many cancers, but especially in cervical cancer it has brought a breakthrough. Very good therapies are already registered for both first- and second-line treatment. Refunds, unfortunately, are not. This is a change expected and desired...
Once a year, the Agency for Health Technology Assessment and Tarification prepares a list of highly innovative drug technologies for the Minister of Health. What therapies are included in the proposals to the MZ?
The Health Ministry has published the new composition of the Economic Commission. The Economic Commission is a team that conducts price negotiations with applicants for reimbursement of drugs, foodstuffs for special nutritional purposes and medical devices. The Commission, in accordance with...
On Tuesday, March 19, the next meeting of the Transparency Council.
Gynecology, gynecologic oncology, cardiology and rare diseases are areas where there will be changes regarding treatment as a result of the new list of reimbursed drugs coming into effect. Patients have gained access to reimbursement for 7 therapies in oncology indications and 26 non-oncology...
The latest list of reimbursed drugs includes 33 new substances, including seven in oncology indications. - This is the largest expansion of the reimbursement list since 2012, says Health Minister Izabela Leszczyna.
As announced by Health Minister Izabela Leszczyna, starting April 1 this year, patients will pay 10% less for drugs made in Poland and 15% less - if, in addition, ingredients made in our country were used in their production.
Achondroplasia is a rare genetic disease manifested, among other things, by short stature. About 560 children in Poland struggle with it. The Children's Ombudsman and the Patient Ombudsman have made a joint request to the manufacturer of the drug, which is intended for children affected by...
Endometriosis is a condition that affects about 6 to 10% of women between the ages of 15 and 49. As experts estimate, the disease may affect up to 3 million women in our country. The main problem is the late diagnosis of the disease, after an average of 6-8 years of pain disabling women from...
The Chief Pharmaceutical Inspector has decided to suspend nationwide marketing of the medicinal product named Paracetamol Aflofarm (Paracetamolum) oral suspension, 120 mg/5 ml, 1 bottle 100 ml GTIN 05909991076115 for the following series: Lot number: 04AF0622, expiration date: 30.06.2025 Lot...
An interview with Professor Krzysztof Giannopoulos of the Department of Experimental Hematooncology at the Medical University of Lublin.
Interview with Zbigniew Pawlowski, president of the Association of Families of Patients with Amyloidosis.
Today (March 4) another meeting of the Transparency Council.
The Minister of Health reminds that important changes to annual prescriptions come into effect on March 1, 2024.
Although we most often talk about depression as a stand-alone disease entity, it is worth being aware that it can occur in the course of bipolar disorder. This raises challenges of diagnosis and treatment. Unfortunately, not all options in pharmacotherapy are available to pediatric patients in...
- I would like to create an IVF program for 2024. I am committed to ensuring that every couple affected by infertility can afford it, Health Minister Izabela Leszczyna said during the first meeting of the ministerial team on IVF.
Opublikowano rozporządzenie MZ z 14 lutego w sprawie leków recepturowych.
On Monday, February 26, the next meeting of the Transparency Council.
The Polish senior citizen's medicine cabinet is usually pathological, we have a great deal of unnecessary drugs and pathosupplementation. There is also a problem with so-called invalidating pharmacotherapy, when, as a result of drug complications and side effects, seniors feel increasingly...
Access to treatment of hemato-oncology diseases needs further optimization. More reimbursement decisions are needed. With access to modern first-line drugs, patients get much better treatment outcomes and are much less burdened by the therapeutic process. This is also a real benefit for the...
W poniedziałek 19 lutego kolejne posiedzenie Rady Przejrzystości.
Are we treating acute myeloid leukemia in Poland according to international guidelines? How do targeted therapies change the treatment outlook? Prof. Agnieszka Wierzbowska of the Department of Hematology at the Medical University of Lodz says.
A Notice of the Minister of Health dated February 7, 2024 on the list of medicinal products, foodstuffs for special nutritional purposes and medical devices at risk of unavailability on the territory of the Republic of Poland has been published in the Official Journal of the Ministry of Health.
A decision on the morning-after pill will be made at the next session of the Sejm. The Confederation filed a motion during the second reading to reject the draft amendment to the Pharmaceutical Law, so the project must be dealt with by the Health Committee.
Acute myeloid leukemia is one of the relatively rare hematopoietic malignancies. We discuss the diagnostic and therapeutic challenges with Professor Lidia Gil of the Department of Hematology and Bone Marrow Transplantation at the Poznan University of Medical Sciences.
- Anesthesiology takes patient safety as its starting point. Anyone undergoing sedation or anesthesia must first and foremost be safe," Professor Janusz Andres, president of the Polish Society of Anesthesiology and Intensive Care, told Medexpress in an interview.
© 2023 Medexpress. All Rights Reserved
